Malonyl-CoA and AMP-activated protein kinase: an expanding partnership - PubMed (original) (raw)

Review

. 2003 Nov;253(1-2):65-70.

doi: 10.1023/a:1026053302036.

Affiliations

• PMID: 14619957
• DOI: 10.1023/a:1026053302036

Review

Malonyl-CoA and AMP-activated protein kinase: an expanding partnership

Asish K Saha et al. Mol Cell Biochem. 2003 Nov.

Abstract

Insulin resistance in skeletal muscle is present in humans with type 2 diabetes (noninsulin-dependent diabetes mellitus) and obesity and in rodents with these disorders. Malonyl CoA is a regulator of carnitine palmitoyl transferase I (CPT I), the enzyme that controls the transfer of long chain fatty acyl CoA into mitochondria where it is oxidized. In rat skeletal muscle, the formation of malonyl CoA is regulated acutely (in minutes) by changes in the activity of acetyl CoA carboxylase (ACC), the enzyme that catalyzes malonyl CoA synthesis. ACC activity can be regulated by changes in the concentration of citrate which is both an allosteric activator of ACC and a source of its precursor, cytosolic acetyl CoA. Increases in cytosolic citrate leading to an increase in the concentration of malonyl CoA occur when muscle is presented with insulin and glucose, or when it is made inactive by denervation. In contrast, exercise lowers the concentration of malonyl CoA, by activating an AMP activated protein kinase (AMPK), which phosphorylates and inhibits ACC. Recently we have shown that the activity of malonyl CoA decarboxylase (MCD), an enzyme that degrades malonyl CoA, is also regulated by phosphorylation. The concentration of malonyl CoA in liver and muscle in certain circumstances correlates inversely with changes in MCD activity. This review will describe the current literature on the regulation of malonyl CoA/AMPK mechanism and its physiological function.

PubMed Disclaimer

Similar articles

• Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.
  Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, Ruderman NB, Saha AK. Park H, et al. J Biol Chem. 2002 Sep 6;277(36):32571-7. doi: 10.1074/jbc.M201692200. Epub 2002 Jun 13. J Biol Chem. 2002. PMID: 12065578
• Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase.
  Rubink DS, Winder WW. Rubink DS, et al. J Appl Physiol (1985). 2005 Apr;98(4):1221-7. doi: 10.1152/japplphysiol.00621.2004. Epub 2004 Dec 3. J Appl Physiol (1985). 2005. PMID: 15579580
• AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
  Assifi MM, Suchankova G, Constant S, Prentki M, Saha AK, Ruderman NB. Assifi MM, et al. Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E794-800. doi: 10.1152/ajpendo.00144.2005. Epub 2005 Jun 14. Am J Physiol Endocrinol Metab. 2005. PMID: 15956049
• Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity.
  Ruderman NB, Saha AK, Vavvas D, Kurowski T, Laybutt DR, Schmitz-Peiffer C, Biden T, Kraegen EW. Ruderman NB, et al. Adv Exp Med Biol. 1998;441:263-70. doi: 10.1007/978-1-4899-1928-1_24. Adv Exp Med Biol. 1998. PMID: 9781332 Review.
• Malonyl-CoA, fuel sensing, and insulin resistance.
  Ruderman NB, Saha AK, Vavvas D, Witters LA. Ruderman NB, et al. Am J Physiol. 1999 Jan;276(1):E1-E18. doi: 10.1152/ajpendo.1999.276.1.E1. Am J Physiol. 1999. PMID: 9886945 Review.

Cited by

• A Novel Multi-Ingredient Supplement Activates a Browning Program in White Adipose Tissue and Mitigates Weight Gain in High-Fat Diet-Fed Mice.
  Nederveen JP, Manta K, Bujak AL, Simone AC, Fuda MR, Nilsson MI, Hettinga BP, Hughes MC, Perry CGR, Tarnopolsky MA. Nederveen JP, et al. Nutrients. 2021 Oct 22;13(11):3726. doi: 10.3390/nu13113726. Nutrients. 2021. PMID: 34835983 Free PMC article.
• Consumption of clarified grapefruit juice ameliorates high-fat diet induced insulin resistance and weight gain in mice.
  Chudnovskiy R, Thompson A, Tharp K, Hellerstein M, Napoli JL, Stahl A. Chudnovskiy R, et al. PLoS One. 2014 Oct 8;9(10):e108408. doi: 10.1371/journal.pone.0108408. eCollection 2014. PLoS One. 2014. PMID: 25296035 Free PMC article.
• Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells.
  Quan HY, Kim DY, Chung SH. Quan HY, et al. BMB Rep. 2013 Apr;46(4):207-12. doi: 10.5483/bmbrep.2013.46.4.153. BMB Rep. 2013. PMID: 23615262 Free PMC article.
• Characterization of the 3'UTR of the BTD gene and identification of regulatory elements and microRNAs.
  Silva GCV, Borsatto T, Schwartz IVD, Sperb-Ludwig F. Silva GCV, et al. Genet Mol Biol. 2022 Feb 14;45(1):e20200432. doi: 10.1590/1678-4685-GMB-2020-0432. eCollection 2022. Genet Mol Biol. 2022. PMID: 35167647 Free PMC article.
• Long term liver specific glucokinase gene defect induced diabetic cardiomyopathy by up regulating NADPH oxidase and down regulating insulin receptor and p-AMPK.
  Li H, Wang X, Mao Y, Hu R, Xu W, Lei Z, Zhou N, Jin L, Guo T, Li Z, Irwin DM, Niu G, Tan H. Li H, et al. Cardiovasc Diabetol. 2014 Jan 22;13:24. doi: 10.1186/1475-2840-13-24. Cardiovasc Diabetol. 2014. PMID: 24447392 Free PMC article.

References

1. 1. Biochem J. 2000 Sep 1;350 Pt 2:599-608 - PubMed
2. 1. Biochem J. 2000 Aug 15;350 Pt 1:61-7 - PubMed
3. 1. Am J Physiol. 1995 Aug;269(2 Pt 1):E283-9 - PubMed
4. 1. Am J Physiol. 1990 Aug;259(2 Pt 1):E266-71 - PubMed
5. 1. Eur J Biochem. 1997 Jun 1;246(2):259-73 - PubMed

Publication types

MeSH terms

Substances